Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients
- Resource Type
- article
- Authors
- Min Chen; Kai Gao; Kamran Ali; Jinpeng Shan; YunMi Qiu; Tianci Xie; Yiling Yu; Liming Wu
- Source
- Frontiers in Medicine, Vol 10 (2023)
- Subject
- Staphylococcus aureus infection
adverse event
atopic dermatitis
dupilumab adverse reactions
drug reaction
Medicine (General)
R5-920
- Language
- English
- ISSN
- 2296-858X
Dupilumab was the first biological medication licensed to treat atopic dermatitis (AD), and it has shown remarkable effectiveness and safety in the treatment of moderate-to-severe atopic dermatitis. There are limited drug-related adverse events associated with dupilumab in atopic dermatitis (AD) treatment. Here, we present two cases of local Staphylococcus aureus infection during the treatment of atopic dermatitis with dupilumab.